rs116154722
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_024915.4(GRHL2):c.*6G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000389 in 1,575,746 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )
Consequence
GRHL2
NM_024915.4 3_prime_UTR
NM_024915.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.370
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 8-101666709-G-A is Benign according to our data. Variant chr8-101666709-G-A is described in ClinVar as [Benign]. Clinvar id is 46213.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00212 (323/152250) while in subpopulation AFR AF= 0.00741 (308/41550). AF 95% confidence interval is 0.00673. There are 1 homozygotes in gnomad4. There are 165 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRHL2 | NM_024915.4 | c.*6G>A | 3_prime_UTR_variant | 16/16 | ENST00000646743.1 | NP_079191.2 | ||
GRHL2 | NM_001330593.2 | c.*6G>A | 3_prime_UTR_variant | 16/16 | NP_001317522.1 | |||
GRHL2 | XM_011517306.4 | c.*6G>A | 3_prime_UTR_variant | 16/16 | XP_011515608.1 | |||
GRHL2 | XM_011517307.4 | c.1763+2191G>A | intron_variant | XP_011515609.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRHL2 | ENST00000646743.1 | c.*6G>A | 3_prime_UTR_variant | 16/16 | NM_024915.4 | ENSP00000495564.1 | ||||
GRHL2 | ENST00000395927.1 | c.*6G>A | 3_prime_UTR_variant | 16/16 | 2 | ENSP00000379260.1 |
Frequencies
GnomAD3 genomes AF: 0.00212 AC: 322AN: 152132Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
322
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000510 AC: 128AN: 250998Hom.: 1 AF XY: 0.000347 AC XY: 47AN XY: 135628
GnomAD3 exomes
AF:
AC:
128
AN:
250998
Hom.:
AF XY:
AC XY:
47
AN XY:
135628
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000204 AC: 290AN: 1423496Hom.: 0 Cov.: 26 AF XY: 0.000156 AC XY: 111AN XY: 710802
GnomAD4 exome
AF:
AC:
290
AN:
1423496
Hom.:
Cov.:
26
AF XY:
AC XY:
111
AN XY:
710802
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00212 AC: 323AN: 152250Hom.: 1 Cov.: 32 AF XY: 0.00222 AC XY: 165AN XY: 74436
GnomAD4 genome
AF:
AC:
323
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
165
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 11, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | *6G>A in Exon 16 of GRHL2: This variant is not expected to have clinical signifi cance because it has been identified in 0.7% (28/3738) of African American chrom osomes from a broad population by the NHLBI Exome Sequencing Project (http://evs .gs.washington.edu/EVS; dbSNP rs116154722). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at